相关实验视频
Updated: Jun 10, 2025

12:03
In Vivo Model for Testing Effect of Hypoxia on Tumor Metastasis
Published on: December 9, 2016
12.4K
儿科尤文肉瘤呈现,治疗和结果跨越社会人口群体
Connor D Fritz1, Anthony V Basta1, Jonathan Gill2
1Department of Surgical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas.
The Journal of surgical research
|October 13, 2024
概括
社会人口统计学显著影响尤文肉瘤的结果. 西班牙裔和亚洲裔患者的生存率更差,而黑人患者接受的化疗更少,突出了护理方面的差异.
科学领域:
- 儿科瘤学 儿科瘤学
- 癌症流行病学 癌症流行病学
- 健康差异 在健康上的差异
背景情况:
- 尤文肉瘤会影响儿童,青少年和年轻人.
- 社会人口学因素可能会影响疾病的表现,治疗和生存.
- 了解这些关联对于改善患者治疗结果至关重要.
研究的目的:
- 评估社会人口统计 (年龄,种族/种族) 与尤宁肉瘤呈现,治疗和生存之间的关联.
- 为了确定不同的人口群体在护理和结果中的差异.
主要方法:
- 利用来自监测,流行病学和最终结果 (SEER) 数据库的案例级数据.
- 包括0-24岁的患者,在2004年至2020年期间被诊断患有尤文肉瘤.
- 分析了社会人口结构,瘤特征,治疗和生存之间的关联.
主要成果:
- 与非西班牙裔白人 (NHW) 患者相比,西班牙裔患者更有可能出现较大的瘤和转移.
- 黑人患者接受化疗的频率低于NHW患者.
- 针对特定疾病的五年生存率有所不同,西班牙裔和亚洲裔患者在调整了混杂因素后,死亡风险更高. 青少年和年轻人生存率较低,治疗延迟.
结论:
- 在不同年龄和种族/种族群体之间存在尤宁肉瘤呈现,治疗和生存的显著差异.
- 未来的研究应该针对缺乏服务的人群获得护理的机会.
- 进一步的研究应探讨遗传因素和护理获取障碍.
相关概念视频
Cancer Survival Analysis
328
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
328
Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K

